
European Journal of Medicinal Chemistry p. 767 - 780 (1997)
Update date:2022-07-30
Topics:
Llinares
Devin
Azay
Berge
Fehrentz
Martinez
Bombesin receptor antagonists are possible therapeutic agents due to their ability to act as inhibitors of cellular proliferation. On the basis of our hypothesis on the mechanism of action of gastrin associating an activating enzyme system to the receptor and on the results reported in the litterature, we have synthesized bombesin analogues which have been modified in the C-terminal Leu13-Leu14 amide part. We have shown that modification in the C-terminal part of the bombesin strongly affected the biological activity in rat pancreatic acini. The most potent compound which is described here, H-D-Phe-Gln-Trp-Ala-Val-Gly-His-Leu-Ψ/(CH2)Leu-NH2, was able to recognize the bombesin receptor on rat pancreatic acini (Ki 4.3 nM) and antagonized the bombesin stimulated amylase secretion (Ki 7.7 nM).
View MoreContact:0086 533 2282832
Address:Zibo,Shandong
changsha chenjin chemical technology co.,LtD(expird)
Contact:86-731-84451263
Address:Room 201/217-218, 101 Jingyuan Electronic Technology Co.,Ltd. Testing Center, No.69, Lufeng Road, High-tech Development Zone, Changsha, China
Yingkou Sanzheng New Technology Chemical Industry Co., Ltd.
Contact:+86-417-2927806
Address:yingkou
Lanling Hongchuang Flame Retardant Co., Ltd.
Contact:+86-531-68858132
Address:East Huafeichang Road, Cangshan County, Linyi, Shandong, China (Mainland)
website:https://www.bocsci.com/
Contact:1-631-485-4226
Address:Ramsey Road
Doi:10.1016/j.tet.2008.08.030
(2008)Doi:10.1016/S0020-1693(00)84604-6
(1986)Doi:10.1002/poc.1384
(2008)Doi:10.1007/s13738-021-02159-2
(2021)Doi:10.1246/cl.1986.1597
(1986)Doi:10.1021/jo00386a029
(1987)